Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
10/2005
10/13/2005WO2005070910A3 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
10/13/2005WO2005067644A3 Conjugated small molecules
10/13/2005WO2004099105A3 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives
10/13/2005US20050228029 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228012 Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
10/13/2005US20050228003 Mitotic kinesin inhibitors
10/13/2005US20050227992 Protein kinase inhibitors
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227967 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
10/13/2005US20050227963 Antiinflammatory agents
10/13/2005CA2561977A1 Substituted thiophene derivatives as anti-cancer agents
10/13/2005CA2560691A1 Tricyclic pyrazole kinase inhibitors
10/13/2005CA2558019A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583757A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
10/12/2005EP1583726A2 Activity-based probes, and methods of their preparation and use
10/12/2005EP1359943B1 Biotin-derivates and their conjugates with chelating agents
10/12/2005EP1202964B1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
10/12/2005EP1060163B1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/12/2005EP0954522B1 Novel substituted naphthopyrans
10/12/2005EP0912547B1 New substituted pyridyl keto enols
10/12/2005EP0900085B1 Treatment of excessive aggression with olanzapine
10/12/2005CN1681891A Functional fluorescent dyes
10/12/2005CN1681825A Multipurpose linker compounds and ligands and process for producing the same
10/12/2005CN1681819A 6, 7-dihydro-5H-pyrazolo[1, 2-a]pyrazol-1-ones which control inflammatory cytokines
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681503A Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors
10/12/2005CN1680334A Fused pyrazolyls
10/12/2005CN1680324A Dihydropyridine soft drugs, and related compositions and methods
10/12/2005CN1680314A 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/12/2005CN1679552A Preferential inhibition of release of pro-inflammatory cytokines
10/12/2005CN1222527C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953679 Biosynthesis with enzyme or microorganism, catalyzing hydroxylation reaction, useful as modulators of nuclear hormone receptor, anticarcinogenic agents, immunomodulators, steroid mimic
10/06/2005WO2005092910A1 Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092825A1 Process for production of optically active alcohols
10/06/2005WO2005063708A3 Processes for preparing different forms of (s)-(+)- clopidogrel bisulfate
10/06/2005US20050222241 Pyrrole derivative and process for producing the same
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222199 Process for the preparation of a hydrate of an antranilic acid derivative
10/06/2005US20050222176 Piperidinylamino-thieno[2,3-D] pyrimidine compounds
10/06/2005US20050222175 New piperidinylamino-thieno[2,3-D] pyrimidine compounds
10/06/2005US20050222174 N-{4-[1-(2,6-difluorobenzyl)-3-(4-fluorophenyl)-5-({methy[2-(2-oxo-1-piperidinyl)ethyl]amino}methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-N'-ethylurea; antagonistic action for gonadotropin-releasing hormone
10/06/2005US20050222162 Administering, to a patient in need of such treatment, an effective amount of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine or a salt thereof
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2558357A1 Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules
10/05/2005EP1581561A2 Spirotetrathiocarbamates and spirooxothiocarbamates
10/05/2005EP1581537A1 A process for the preparation of a pharmaceutically pure polymorphic form i of olanzapine
10/05/2005EP1581478A1 Dhodh-inhibitors and method for their identification
10/05/2005EP1581477A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
10/05/2005EP1581262A2 Contrast agent
10/05/2005EP1581220A2 2-nh-heteroarylimidazoles with antibacterial activity
10/05/2005EP1404683B1 Polymerisable charge transport compounds
10/05/2005CN1678593A Microbiocidal (e.g. fungicidal) 1, 2, 3-triazole derivatives
10/05/2005CN1678203A Novel nutraceutical compositions comprising biotin
10/05/2005CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
10/04/2005US6951949 such as 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide for treatment of arthritis
10/04/2005US6951878 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
09/2005
09/29/2005WO2005090359A2 Synthesis of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2, 3-b][1,5]benzodiazepine and salts thereof
09/29/2005WO2005073224A3 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
09/29/2005WO2005054234A3 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
09/29/2005WO2005009398A3 Tetracyclic benzamide derivatives and methods of use thereof
09/29/2005WO2003099822A3 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/29/2005US20050215613 with indazole or thienopyrazole compounds such as 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl-indazole
09/29/2005US20050215612 Anticancer agents; such as succinic acid mono-[5-(1-benzyl-1H-indazol-3-yl)-furan-2-ylmethyl]ester, sodium salt; inhibit cancer cell growth
09/29/2005DE10393290T5 Clopidogrel Clopidogrel
09/29/2005CA2558654A1 Synthesis of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2, 3-b][1,5]benzodiazepine and salts thereof
09/28/2005EP1578741A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
09/28/2005EP1086099B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
09/28/2005CN1675221A Process for producing cyclic thioether and synthetic intermediate thereof
09/27/2005US6949651 A thiazolo(5,4-b)pyridine-5,7-dione derivatives for treating arthritis, inflammation, cancer
09/27/2005US6949648 Condensed pyrazole derivatives, process for producing the same and use thereof
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/27/2005US6949341 Diagnosing genetic disorders
09/27/2005CA2245680C Method of detection of influenza virus and compounds for use therein
09/22/2005WO2005087780A1 Chalcogen-containing fused-ring polycyclic organic material and process for producing the same
09/22/2005WO2005087779A1 Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used therein
09/22/2005WO2005087746A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
09/22/2005WO2005087225A1 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents
09/22/2005WO2005032527B1 Benzo (4, 5) thieno (2, 3-d) pyrimidin-4-ones and their use in therapy
09/22/2005US20050209296 1,2-Diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050209273 Neuroprotectants, analgesics or anticonvulsants
09/22/2005US20050209262 Process for producing optically active sulfoxide
09/22/2005US20050209233 Neuropeptide Y5 (NPY-5) receptor antagonists or agonists; eating disorders, diabetes dyslipidemia, hypertension, and sleep disorders; pyridazin-3-ylamino-substituted dibenzothiophenes and S-oxides thereof
09/22/2005US20050209214 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050209191 1-Aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050208582 Pyrazole compounds and pharmaceutical compositions comprising the compound
09/21/2005EP1577296A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their use
09/21/2005EP1577295A1 Process for preparing 2-oxo-1-pyrrolidine derivatives as intermediates
09/21/2005EP1576954A1 Preferential inhibition of release of pro-inflammatory cytokines
09/21/2005EP1575962A1 Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
09/21/2005EP1575961A1 Method for the decarboxylation of dicarboxylic acids
09/21/2005EP1575951A1 Heterocyclic compounds, methods of making them and their use in therapy
09/21/2005EP1575925A1 Novel carboxamides, the production and use thereof as medicaments
09/21/2005EP1265862B1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/21/2005EP1201667B1 Polymerizable biotin derivatives, biotin polymer, and polymer responsive to avidin stimulation
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 214